Amal Arahmani
- Oncology top 5%
- Cancer Research top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Co-authors
- Giuseppe VialeEvandro de AzambujaRichard D. GelberMartine PiccartDimitrios ZardavasGϋnter von MinckwitzDenise A. YardleyJosé Bines
- Topics
- HER2/EGFR in Cancer Research (9 papers)Advanced Breast Cancer Therapies (8 papers)Breast Cancer Treatment Studies (7 papers)
- Partner nations
- BelgiumItalyUnited States
In The Last Decade
Amal Arahmani
20 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 836
- Cancer Research 430
- Radiology, Nuclear Medicine and Imaging 301
- Pulmonary and Respiratory Medicine 295
- Molecular Biology 151
Countries citing papers authored by Amal Arahmani
This map shows the geographic impact of Amal Arahmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal Arahmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal Arahmani more than expected).
Fields of papers citing papers by Amal Arahmani
This network shows the impact of papers produced by Amal Arahmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal Arahmani. The network helps show where Amal Arahmani may publish in the future.
Co-authorship network of co-authors of Amal Arahmani
This figure shows the co-authorship network connecting the top 25 collaborators of Amal Arahmani. A scholar is included among the top collaborators of Amal Arahmani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal Arahmani. Amal Arahmani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 8 | |
| 7 | 5 | |
| 8 | 18 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 2 | |
| 12 | 5 | |
| 13 | 1 | |
| 14 | 16 | |
| 15 | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancerbreakdown → | 918 |
| 16 | 0 | |
| 17 | 9 | |
| 18 | 16 | |
| 19 | 1 | |
| 20 | 4 |
About Amal Arahmani
Amal Arahmani is a scholar working on Cancer Research, Oncology and Behavioral Neuroscience, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Advanced Breast Cancer Therapies (8 papers) and Breast Cancer Treatment Studies (7 papers). The work is most often cited by research in Oncology (836 citations), Cancer Research (430 citations) and Radiology, Nuclear Medicine and Imaging (301 citations). Amal Arahmani has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Giuseppe Viale, Evandro de Azambuja, Richard D. Gelber, Martine Piccart, Dimitrios Zardavas, Gϋnter von Minckwitz, Denise A. Yardley, José Bines, István Láng and Mark Benyunes. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.